Some key players are concerned with the proposed Bill’s impact on the advertising of therapeutic goods to consumers.

Ken Harvey says "A review of the pre-approval system found most of the new advertisements needed changes to avoid breaching the TGA code and the concern is that if we eliminate it and rely on penalties down the track there's nothing stopping bad ads for a cure for cancer appearing in the newspaper and getting a large number of customers." 

Announced 7 July 2017

From 1 July 2018, the Therapeutic Goods Administration (TGA) will assume responsibility for receiving and considering all complaints about therapeutic goods advertisements directed to the public and other aspects of the therapeutic goods advertising framework, including the pre-approvals scheme will be overhauled.